By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222



Company News
MorphoSys AG Starts Phase III Trial Of MOR208 Plus Bendamustine In Patients With Relapsed Or Refractory DLBCL 6/6/2017 3:29:50 PM
MorphoSys AG Presents First Safety And Efficacy Data Of MOR208 In Combination With Lenalidomide From A Phase II Study In DLBCL 6/6/2017 2:10:38 PM
MorphoSys AG Presents Updated Clinical Data For Anti-CD38 Antibody MOR202 In Multiple Myeloma At ASCO 2017 6/5/2017 5:12:24 PM
MorphoSys AG To Present At Three Upcoming Conferences 5/24/2017 1:05:47 PM
MorphoSys AG Announces That Its Licensee Janssen R&D Reported Updates On The Development Of Guselkumab 5/24/2017 1:03:04 PM
MorphoSys AG Announces First Results From Phase I Study With Lanthipeptide MOR107 In Healthy Volunteers 5/19/2017 11:16:16 AM
MorphoSys AG To Present Clinical Data On Proprietary Programs At Upcoming ASCO Annual Meeting 2017 5/18/2017 1:25:33 PM
MorphoSys AG Reports Outcome Of Annual General Meeting 2017 5/17/2017 10:42:45 AM
MorphoSys AG Reports Solid First Quarter 2017 5/3/2017 10:03:29 AM
MorphoSys AG To Host Q1 2017 Conference Call On May 3, 2017 4/24/2017 11:10:02 AM